Market Disclosure
ECS Botanics announces UK distribution and manufacturing agreement with Curaleaf Laboratories
ECS Botanics Holdings told the ASX on 7 October 2026 it has entered a distribution and manufacturing agreement with Curaleaf Laboratories for ECS-branded medicinal cannabis in the UK.